Department of Obstetrics, Zibo Maternal and Child Health Hospital, Zibo, 255000, Shandong, People's Republic of China.
Department of Neurology, Jinan No.7 People's Hospital, Jinan, 251400, Shandong, People's Republic of China.
Reprod Sci. 2021 May;28(5):1370-1381. doi: 10.1007/s43032-020-00398-x. Epub 2021 Jan 6.
Reduced activity of trophoblast cells is well-recognized to lead to preeclampsia (PE) progression. This study aims to evaluate the roles of histone deacetylase sirtuin 2 (SIRT2) in activity of trophoblast cells and the molecules involved. Differentially expressed genes in placental tissues between PE patients and healthy individuals were screened using microarray analyses. SIRT2 and atypical chemokine receptor 2 (ACKR2) were downregulated while miR-146a was upregulated in PE patients. SIRT2 was localized in placental syncytiotrophoblasts. Upregulation of SIRT2 enhanced viability, migration and invasion, while reduced apoptosis of HTR-8/SVneo cells. SIRT2 was found to trigger p65 deacetylation level and suppress miR-146a expression according to the luciferase and ChIP assays, whereas miR-146a was found to target ACKR2. Downregulation of p65 promoted migration and invasion of cells. Overexpression of miR-146a inhibited cell viability and blocked the function of SIRT2. ACKR2 was downregulated in tissues from PE women and its upregulation blocked the role of miR-146a. To conclude, SIRT2 promotes p65 deacetylation to suppress miR-146a expression and upregulates ACKR2 expression, therefore enhancing proliferation, migration, and invasion of HTR-8/SVneo cells. This study may offer novel thoughts into the management of PE.
滋养细胞活性降低被认为是子痫前期(PE)进展的主要原因。本研究旨在评估组蛋白去乙酰化酶沉默调节因子 2(SIRT2)在滋养细胞活性及相关分子中的作用。采用基因芯片分析筛选 PE 患者和健康个体胎盘组织中的差异表达基因。PE 患者中 SIRT2 和非典型趋化因子受体 2(ACKR2)表达下调,miR-146a 表达上调。SIRT2 定位于胎盘合体滋养细胞。上调 SIRT2 可增强 HTR-8/SVneo 细胞活力、迁移和侵袭能力,同时减少细胞凋亡。根据荧光素酶和 ChIP 实验,发现 SIRT2 可触发 p65 去乙酰化水平并抑制 miR-146a 表达,而 miR-146a 可靶向 ACKR2。下调 p65 可促进细胞迁移和侵袭。过表达 miR-146a 可抑制细胞活力并阻断 SIRT2 的功能。PE 患者组织中 ACKR2 表达下调,其上调可阻断 miR-146a 的作用。总之,SIRT2 可促进 p65 去乙酰化,抑制 miR-146a 表达,上调 ACKR2 表达,从而增强 HTR-8/SVneo 细胞的增殖、迁移和侵袭能力。本研究可能为 PE 的治疗提供新的思路。